Livzon Pharmaceutical Group Inc. (LVZPF) Comparison with companies in other sectors?

Livzon Pharmaceutical Group Inc. has a share price of 1.01B. You can analyze Livzon Pharmaceutical Group Inc. (LVZPF) competitors across different market sectors through stock heatmaps.

What are LVZPF's NET and operating margins?

Livzon Pharmaceutical Group Inc. (LVZPF) operating margin is around 0.25, and net profit margin is approximately 0.18 as of the latest reports.

In what way does LVZPF's earnings per share (EPS) trend reflect its financial momentum?

Livzon Pharmaceutical Group Inc. (LVZPF) EPS is 0.30 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Livzon Pharmaceutical Group Inc. is 11.43, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Livzon Pharmaceutical Group Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Livzon Pharmaceutical Group Inc. like P/E which is 10.55, P/B which is 1.56, and PEG which is 0.55. Compare them with sector averages to evaluate if the stock is priced fairly.

Livzon Pharmaceutical Group Inc.

LVZPF•PNK

Healthcare

Drug Manufacturers - Specialty & Generic

$3.43

$0.00(0.00%)

Fundamental Analysis of Livzon Pharmaceutical Group Inc. (LVZPF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.30

P/E Ratio

11.43

ROE

0.15%

Net Margin

0.18%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$3.47B

Shares OutstandingTotal number of shares issued

$1.01B

Book Value/ShareNet worth per share

$17.15

Revenue/ShareAnnual revenue per share

$13.06

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.3

Net MarginNet income as percentage of revenue

17.84%

Operating MarginOperating income as percentage of revenue

24.95%

ROEReturn on shareholders' equity

14.90%

ROAReturn on total assets

8.54%

ROCEReturn on capital employed

16.94%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$2.48

Cash/ShareCash and equivalents per share

$12.15

FCF YieldFree cash flow as percentage of market cap

8.95%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$1.09

Dividend YieldAnnual dividend as percentage of stock price

4.45%

Financial Ratios Analysis data is not available for LVZPFFinancial Ratios Analysis details for LVZPF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for LVZPFSector Benchmarking details for LVZPF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Livzon Pharmaceutical Group Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Livzon Pharmaceutical Group Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Livzon Pharmaceutical Group Inc.'s unique business strengths and challenges.

Key Financial Metrics for Livzon Pharmaceutical Group Inc.

For Livzon Pharmaceutical Group Inc., essential financial indicators include EPS 0.30, PE 11.43, and ROE 0.15. These key ratios reveal insights into Livzon Pharmaceutical Group Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Livzon Pharmaceutical Group Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Livzon Pharmaceutical Group Inc.

Metrics like Net Margin 17.84% and ROA 8.54% shed light on how well Livzon Pharmaceutical Group Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Livzon Pharmaceutical Group Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Livzon Pharmaceutical Group Inc.

Using ratios such as P/B Ratio 1.56 and PEG Ratio 0.55, investors can assess whether Livzon Pharmaceutical Group Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Livzon Pharmaceutical Group Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Livzon Pharmaceutical Group Inc.

Financial health indicators, such as Debt/Equity Ratio 0.27 and Cash Flow $2.48, provide a snapshot of Livzon Pharmaceutical Group Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Livzon Pharmaceutical Group Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Livzon Pharmaceutical Group Inc.

Investing in Livzon Pharmaceutical Group Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Livzon Pharmaceutical Group Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;